These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21651975)

  • 1. High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis.
    van de Water FM; Havinga J; Ravesloot WT; Horbach GJ; Schoonen WG
    Toxicol In Vitro; 2011 Dec; 25(8):1870-82. PubMed ID: 21651975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development.
    Fujimura H; Dekura E; Kurabe M; Shimazu N; Koitabashi M; Toriumi W
    Exp Toxicol Pathol; 2007 Aug; 58(6):375-82. PubMed ID: 17408938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of an in vitro high-throughput screening assay for detecting phospholipidosis-inducing potential.
    Kasahara T; Tomita K; Murano H; Harada T; Tsubakimoto K; Ogihara T; Ohnishi S; Kakinuma C
    Toxicol Sci; 2006 Mar; 90(1):133-41. PubMed ID: 16338956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation and validation of multiple cell lines and primary mouse macrophages to predict phospholipidosis potential.
    LeCureux L; Cheng CS; Herbst J; Reilly TP; Lehman-McKeeman L; Otieno M
    Toxicol In Vitro; 2011 Dec; 25(8):1934-43. PubMed ID: 21767630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S; Matsumoto A; Mori I; Horinouchi A
    Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of an in vitro screen for phospholipidosis using a high-content biology platform.
    Morelli JK; Buehrle M; Pognan F; Barone LR; Fieles W; Ciaccio PJ
    Cell Biol Toxicol; 2006 Jan; 22(1):15-27. PubMed ID: 16463016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro assays and biomarkers for drug-induced phospholipidosis.
    Monteith DK; Morgan RE; Halstead B
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):687-96. PubMed ID: 17014389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies.
    Nioi P; Perry BK; Wang EJ; Gu YZ; Snyder RD
    Toxicol Sci; 2007 Sep; 99(1):162-73. PubMed ID: 17567588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach.
    Bauch C; Bevan S; Woodhouse H; Dilworth C; Walker P
    Toxicol In Vitro; 2015 Apr; 29(3):621-30. PubMed ID: 25668432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase.
    Natalie M; Margino S; Erik H; Annelieke P; Geert V; Philippe V
    Toxicol In Vitro; 2009 Mar; 23(2):217-26. PubMed ID: 19101623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipidosis assay in HepG2 cells and rat or rhesus hepatocytes using phospholipid probe NBD-PE.
    Bhandari N; Figueroa DJ; Lawrence JW; Gerhold DL
    Assay Drug Dev Technol; 2008 Jun; 6(3):407-19. PubMed ID: 18537465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From the Cover: Potentiation of Drug-Induced Phospholipidosis In Vitro through PEGlyated Graphene Oxide as the Nanocarrier.
    Yang L; Zhong X; Li Q; Zhang X; Wang Y; Yang K; Zhang LW
    Toxicol Sci; 2017 Mar; 156(1):39-53. PubMed ID: 28013220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system.
    Sawada H; Takami K; Asahi S
    Toxicol Sci; 2005 Feb; 83(2):282-92. PubMed ID: 15342952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for phospholipidosis induced by central nervous drugs: comparing the predictivity of an in vitro assay to high throughput in silico assays.
    Mesens N; Steemans M; Hansen E; Verheyen GR; Van Goethem F; Van Gompel J
    Toxicol In Vitro; 2010 Aug; 24(5):1417-25. PubMed ID: 20430096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the phospholipidogenic potential of 4(1H)-pyridone antimalarial derivatives.
    Almela MJ; Torres PA; Lozano S; Herreros E
    Toxicol In Vitro; 2009 Dec; 23(8):1528-34. PubMed ID: 19540329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis.
    Tilmant K; Gerets HH; Dhalluin S; Hanon E; Depelchin O; Cossu-Leguille C; Vasseur P; Atienzar FA
    Toxicol In Vitro; 2011 Oct; 25(7):1414-24. PubMed ID: 21515356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of phospholipidosis induction: a cell-based assay in high-throughput and high-content format.
    Shahane SA; Huang R; Gerhold D; Baxa U; Austin CP; Xia M
    J Biomol Screen; 2014 Jan; 19(1):66-76. PubMed ID: 24003057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone.
    Natale A; Boeckmans J; Desmae T; De Boe V; De Kock J; Vanhaecke T; Rogiers V; Rodrigues RM
    Toxicol Lett; 2018 Mar; 284():184-194. PubMed ID: 29248575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a high-content screening in vitro micronucleus assay in CHO-k1 and HepG2 cells.
    Westerink WM; Schirris TJ; Horbach GJ; Schoonen WG
    Mutat Res; 2011 Sep; 724(1-2):7-21. PubMed ID: 21658468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting phospholipidosis: a fluorescence noncell based in vitro assay for the determination of drug-phospholipid complex formation in early drug discovery.
    Zhou L; Geraci G; Hess S; Yang L; Wang J; Argikar U
    Anal Chem; 2011 Sep; 83(18):6980-7. PubMed ID: 21790130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.